These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 28660746)

  • 1. Pronase treatment improves flow cytometry crossmatching results.
    Apithy MJ; Desoutter J; Gicquel A; Guiheneuf E; Westeel PF; Lesage A; Piot V; Choukroun G; Guillaume N
    HLA; 2017 Sep; 90(3):157-164. PubMed ID: 28660746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved flow cytometry crossmatching in kidney transplantation.
    Guillaume N
    HLA; 2018 Dec; 92(6):375-383. PubMed ID: 30270577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pronase independent flow cytometry crossmatching of rituximab treated patients.
    Alheim M; Wennberg L; Wikström AC
    Hum Immunol; 2018 Feb; 79(2):132-135. PubMed ID: 29157993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falsely incompatible B-cell flow cytometry crossmatch after pronase treatment: a case report.
    Hart JD; Lutz CT; Jennings CD; May JR; Nelson K; Jacobs S; Hoopes CW
    Transplant Proc; 2015 Apr; 47(3):831-3. PubMed ID: 25891741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reanalysis of the role of pronase treatment of B cells in the flow cytometric crossmatch assay: Fc receptor is not the primary target.
    Brown NK; Meade JR; Wang J; Marino SR
    Hum Immunol; 2017 Nov; 78(11-12):704-709. PubMed ID: 28987959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pronase improves detection of HLA antibodies in flow crossmatches.
    Vaidya S; Cooper TY; Stewart D; Gugliuzza K; Daller J; Bray RA
    Transplant Proc; 2001; 33(1-2):473-4. PubMed ID: 11266914
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of pronase on flow cytometric crossmatch outcome.
    Hetrick SJ; Schillinger KP; Zachary AA; Jackson AM
    Hum Immunol; 2011 Apr; 72(4):330-6. PubMed ID: 21262310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry crossmatch reactivity with pronase-treated T cells induced by non-HLA autoantibodies in human immunodeficiency virus-infected patients.
    Szewczyk K; Barrios K; Magas D; Sieg K; Labuda B; Jendrisak MD; Jaramillo A
    Hum Immunol; 2016 Jun; 77(6):449-55. PubMed ID: 27094930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pronase-free B-cell flow-cytometry crossmatch.
    Hajeer AH; Saleh S; Sutton P; Shubaili A; Anazi H
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):662-5. PubMed ID: 19587513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent false-positive reactions in pronase-treated T-cell flow cytometric cross-match tests.
    Park H; Lim YM; Han BY; Hyun J; Song EY; Park MH
    Transplant Proc; 2012 Jan; 44(1):87-90. PubMed ID: 22310587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric detection of complement-activating HLA antibodies.
    Schönemann C; Lachmann N; Kiesewetter H; Salama A
    Cytometry B Clin Cytom; 2004 Nov; 62(1):39-45. PubMed ID: 15476206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pronase treatment facilitates alloantibody flow cytometric and cytotoxic crossmatching in the presence of rituximab.
    Bearden CM; Agarwal A; Book BK; Sidner RA; Gebel HM; Bray RA; Pescovitz MD
    Hum Immunol; 2004 Aug; 65(8):803-9. PubMed ID: 15336781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of pronase-digested human leukocytes to improve specificity of the flow cytometric crossmatch.
    Lobo PI; Spencer CE; Stevenson WC; McCullough C; Pruett TL
    Transpl Int; 1995; 8(6):472-80. PubMed ID: 8579739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody Therapeutics as Interfering Agents in Flow Cytometry Crossmatch for Organ Transplantation.
    Kueht ML; Dongur LP; Mujtaba MA; Cusick MF
    J Pers Med; 2023 Jun; 13(6):. PubMed ID: 37373995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo.
    Quah BJ; Wijesundara DK; Ranasinghe C; Parish CR
    J Immunol Methods; 2013 Jan; 387(1-2):181-90. PubMed ID: 23123200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved specificity and sensitivity when using pronase-digested lymphocytes to perform flow-cytometric crossmatch prior to renal transplantation.
    Lobo PI; Isaacs RB; Spencer CE; Pruett TL; Sanfey HA; Sawyer RG; McCullough C
    Transpl Int; 2002 Nov; 15(11):563-9. PubMed ID: 12461661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two peripheral mononuclear cell isolation protocols for flow cytometry crossmatching.
    Apithy MJ; Desoutter J; Guillaume N
    HLA; 2018 Feb; 91(2):124-126. PubMed ID: 29240309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A flow cytometric crossmatch test for simultaneous detection of antibodies against donor lymphocytes and endothelial precursor cells.
    Alheim M; Johansson SM; Hauzenberger D; Grufman P; Holgersson J
    Tissue Antigens; 2010 Mar; 75(3):269-77. PubMed ID: 20070600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow Cytometric Panel-Reactive Antibody Results and the Ability to Find Transfusion-Compatible Platelets after Antibody-Desensitization for Allogeneic Bone Marrow Transplant.
    Rosenbaum ER; Pandey S; Harville TO; Drobena GA; Cottler-Fox M
    Ann Clin Lab Sci; 2016 Dec; 46(6):662-665. PubMed ID: 27993881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.